RT Journal Article
SR Electronic
T1 1392 EVOLVE-104, a novel ULBP2-targeted T cell engager that integrates CD2 costimulation for the treatment of basal and squamous lineage tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1547
OP A1547
DO 10.1136/jitc-2023-SITC2023.1392
VO 11
IS Suppl 1
A1 Tam, Eric M
A1 Sarkar, Mohosin
A1 Jin, Guixian
A1 Sergeeva, Oksana A
A1 Abulizi, Abudukadier
A1 Lai, Zengzu
A1 Karp, Hayden
A1 Rodriguez, Julio
A1 Hackett, Maria
A1 Martomo, Stella
A1 Dhindwal, Sonali
A1 Teran, Evelyn
A1 Klaskin, Danielle
A1 Lichter, Tracy
A1 Zeiger, Jennifer
A1 Fearnley, Amber
A1 Yuan, Changqing
A1 An, Xingyue
A1 Matis, Louis
A1 Fine, Jay S
A1 Myers, Jeremy S
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1547.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.